Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9010)	3/11/1999 12:12:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Bob, I have read it with care. I need your help to understand your point. I have never teased you, why are you teasing me? <g> Bob, less than 50% of the 2,700 cases had meningococal sepsis, the majority just had meningitis. So the less than 10% death rate is not meaningful Second this standard of care was for 1997, and does not include BPI. "Although mortality rises to 50% in the most severely ill patients,4-6 data from our unit suggests that early recognition,7 aggressive resuscitation, specialist advice, and transfer to paediatric intensive care8 9 can reduce this mortality to less than 5%" The comments on the importance of aggressive resuscitation and specialist as being more important than early treatment were interesting. Even though the report refers to the past I wondered if the comments were not influenced by something occurring now? But in any event please help me, understand exactly what you mean.